We are live on ! Find out more
GF

Gray Foundation Portfolio holdings

AUM $454M
1-Year Est. Return 38.19%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+38.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$399M
AUM Growth
+$47.2M
Cap. Flow
+$14.1M
Cap. Flow %
3.54%
Top 10 Hldgs %
99.16%
Holding
11
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$5.48M
2
BA icon
Boeing
BA
+$5.43M
3
AZN icon
AstraZeneca
AZN
+$3.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 55.12%
2 Communication Services 8.82%
3 Real Estate 2.38%
4 Healthcare 2.19%
5 Industrials 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLT icon
1
Hilton Worldwide
HLT
$74.2B
$210M 52.74%
731,666
IGM icon
2
iShares Expanded Tech Sector ETF
IGM
$10.5B
$72.2M 18.12%
559,116
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.14T
$35.1M 8.82%
112,000
INDA icon
4
iShares MSCI India ETF
INDA
$6.6B
$23M 5.77%
425,748
ROBO icon
5
ROBO Global Robotics & Automation Index ETF
ROBO
$2.04B
$14.2M 3.57%
205,000
SOXX icon
6
iShares Semiconductor ETF
SOXX
$41.4B
$10.4M 2.6%
34,371
HGV icon
7
Hilton Grand Vacations
HGV
$3.48B
$9.51M 2.39%
212,520
INVH icon
8
Invitation Homes
INVH
$18B
$9.47M 2.38%
340,734
BA icon
9
Boeing
BA
$170B
$5.73M 1.44%
+26,400
New +$5.43M
NBIX icon
10
Neurocrine Biosciences
NBIX
$15.5B
$5.36M 1.35%
+37,800
New +$5.48M
AZN icon
11
AstraZeneca
AZN
$255B
$3.36M 0.84%
+18,269
New +$3.2M

Similar funds

Gray Foundation's Q4 2025 Portfolio in Review

As of Q4 2025, Gray Foundation held 11 positions worth $399M, up 13% from $351M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Gray Foundation deployed $14.1M of net new capital in Q4 2025, opening 3 new positions. Its largest new stake was Neurocrine Biosciences: 37,800 shares worth $5.36M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 55% of assets, down from 57% a quarter earlier, followed by Communication Services and Real Estate.

  • Gray Foundation's largest Q4 2025 buy was Neurocrine Biosciences: 37,800 shares worth $5.36M.
  • Gray Foundation's ten largest holdings make up 99% of its $399M portfolio in Q4 2025.
  • Gray Foundation opened 3 new positions and closed 0 in Q4 2025.
  • Gray Foundation's portfolio value rose 13% quarter-over-quarter to $399M.

Based on Gray Foundation's 13F filing for Q4 2025, filed 29 Jan 2026.